Testing effectiveness (Phase 2)Not Yet RecruitingNCT07758491
What this trial is testing
A Phase I/II Study of FG-M131 in TRBC1+ Relapsed/Refractory Peripheral T-Cell Lymphoma
Who this might be right for
PTCLTRBC1 ADCCTCL
FutureGen Biopharmaceutical (Beijing) Co., Ltd 110